Rohto PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Rohto PharmaceuticalLtd has a total shareholder equity of ¥264.3B and total debt of ¥44.5B, which brings its debt-to-equity ratio to 16.8%. Its total assets and total liabilities are ¥408.3B and ¥143.9B respectively. Rohto PharmaceuticalLtd's EBIT is ¥36.8B making its interest coverage ratio -19.7. It has cash and short-term investments of ¥64.5B.
Key information
16.8%
Debt to equity ratio
JP¥44.54b
Debt
| Interest coverage ratio | -19.7x |
| Cash | JP¥64.50b |
| Equity | JP¥264.34b |
| Total liabilities | JP¥143.92b |
| Total assets | JP¥408.26b |
Recent financial health updates
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well
Oct 20
Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?
Jul 11These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely
Apr 03Recent updates
Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 15Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well
Oct 20Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price
Oct 06Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down
Sep 22Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors
Aug 25Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next
Aug 11Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?
Jul 11Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Jun 23Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares
Jun 10Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward
May 14These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely
Apr 03Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching
Mar 21Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year
Mar 07Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Feb 26Financial Position Analysis
Short Term Liabilities: 4527's short term assets (¥204.9B) exceed its short term liabilities (¥111.1B).
Long Term Liabilities: 4527's short term assets (¥204.9B) exceed its long term liabilities (¥32.8B).
Debt to Equity History and Analysis
Debt Level: 4527 has more cash than its total debt.
Reducing Debt: 4527's debt to equity ratio has increased from 2.3% to 16.8% over the past 5 years.
Debt Coverage: 4527's debt is well covered by operating cash flow (88.6%).
Interest Coverage: 4527 earns more interest than it pays, so coverage of interest payments is not a concern.